Tetrodocain

Tetrodocain

Tetrodocain

North Korean medical injection


Tetrodocain (Korean: 테트로도카인주사약) is medical injection produced by the Korea Jangsaeng Joint Venture Company (조선장생합영회사) in North Korea. The injection was first claimed to be invented by the company in 2004.[1] According to the state-run Korean Central News Agency (KCNA), the main ingredient of the injection is tetrodotoxin, isolated from puffer poisons, and operates as an anaesthetic.[2] It has been sold for international export on sites based in Russia and China.[3]

KCNA described the medicine as efficacious in treating a wide range of diseases, including cancer, tuberculosis, chronic hepatitis, pancreatitis and HIV/AIDS.[4][5] These claims have been deemed to be either exaggerated or false.[3] The North Korean government also marketed its use in drug detoxification from narcotics such as opium, cocaine and heroin.[6]

North Korea released a supposed clinical research thesis about the usage of tetrodocain for anesthetics in 2015.[7]

See also


References

  1. "북, 복어 독으로 차세대 진통제 개발". 2004-08-27.
  2. "Natural Tetrodocain Injection". Korea News Service. Korean Central News Agency. 2 September 2009. Archived from the original on 6 September 2009. Retrieved 11 May 2021.
  3. "Efficacious Tetrodocain Injection". Korea News Service. Korean Central News Agency. 26 August 2004. Archived from the original on 2 September 2004. Retrieved 11 May 2021.
  4. "DPRK develops medicines with swellfish poison". People's Daily. Xinhua News Agency. 17 December 2010. Archived from the original on 12 May 2021. Retrieved 11 May 2021.
  5. Hyun, Kwon Jeong (31 December 2005). "The Worst North Korean Export Goods in 2005". Daily NK. Retrieved 11 May 2021.

Share this article:

This article uses material from the Wikipedia article Tetrodocain, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.